105 Implementation of a Lung Cancer Nurse Specialist 2WW Remote Outpatient Triage Clinic – Optimising Patient Access and Assessment
Lung Cancer is known to be a complex and evolving tumour site across the cancer arena. Whilst referrals are lower compared to other higher volume tumour sites, the complexity continues to present challenges for diagnostic and treatment element of the pathway. Significant pressure on medical colleagues in existing Target Cancer Outpatient Clinic model – led to patients being appointed at Day 12 or 13 against the 2 Week NHS England standard. Trust/Clinical Team aspiration to radically improve access to the front-end of the pathway seeking to improve patient outcomes. (Source: Lung Cancer)
Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Richard Sterry, Andrea Worsdale, Leah Taylor, Mark Weatherhad Tags: Nursing and Allied Health Professionals Source Type: research
106 CNS Patient Stratified Follow Up (PSFU) in Oncology/ Surgical Clinics
The implementation of Personalised Stratified Follow-Up (PSFU) models of care in cancer was a key priority of the ‘Living with and beyond cancer’ strategy and subsequently reiterated in the NHS Long Term Plan (2019). PSFU recognises that historic ‘one size fits all ‘ models of follow-up care did not always meet the holistic needs of patients nor represent resilient, efficient use of NHS resources. Addit ionally, where follow-up includes regular surveillance tests, the alignment of remote monitoring solutions to PSFU delivery, will allow patients to be managed without the need for repeated trips to the hospital envi...
Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Peet Toni Tags: Nursing and Allied Health Professionals Source Type: research
107 Introduction of Community Thoracic Advanced Nurse Practitioner 2020 –2023
The Thoracic Surgical service cares for around 800 patients/ year, serving a population of 1.5 million covering North Yorkshire, Teesside and County Durham who undergo thoracic procedures for diagnostic, therapeutic or palliative intent for both benign and malignant disease. With support from Macmillan Cancer Support, we introduced a Community Thoracic Advanced Nurse Practitioner with the aims of actively supporting patients and their families by providing holistic continuity of care throughout the thoracic surgical pathway. (Source: Lung Cancer)
Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Stacey Stockdale, Hayley McNaught, Leanne Connelly, Rachel Calvert Tags: Nursing and Allied Health Professionals Source Type: research
108 Evaluation of a Lung Cancer Nurse led clinic for the routine follow up of uncomplicated post resection lung cancer patients
NICE guidelines recommend offering a protocol driven follow up by a lung cancer nurse specialist (LCNS) for patients after surgery for NSCLC (1) Patients require regular clinical and radiological follow up for prolonged periods with quick access to the wider lung cancer MDT should problems arise. We conducted a service evaluation to confirm that our LCNS clinic was safe, efficient and providing patient satisfaction. The Clinic The clinic serves a lung cancer MDT that manages around 120 diagnoses a year. (Source: Lung Cancer)
Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Emma Watkins, Gemma Morris Tags: Nursing and Allied Health Professionals Source Type: research
109 Developing the role of the Lung Cancer Nurse Specialist (CNS) to support wider Clinical Practice beyond traditional role boundaries
Lung Cancer is known to be a complex and evolving tumour site across the cancer arena. As part of recognising the increasing complexity, clear recognition that Cancer Nurse Specialists could play a bigger part in delivering timely access to initial triage, assessment, care planning, treatment and surveillance. Aim of strategic workforce development was to create advanced practice roles that benefit patients/carers, alongside Nurse Specialists themselves for recruitment and retention. (Source: Lung Cancer)
Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Richard Sterry, Andrea Worsdale, Leah Taylor, Mark Weatherhead Tags: Nursing and Allied Health Professionals Source Type: research
110 Co-creating a psychological prehabilitation document for people preparing for lung cancer treatments
Cancer prehabilitation occurs between the time of diagnosis and the beginning of treatment and includes assessments and interventions that promote physical and psychological health. We sought to co-create with people affected by lung cancer, a document to meet the needs of our diverse East London communities, provide tips on how to psychologically prepare for treatment, reduce isolation and increase connections with others. (Source: Lung Cancer)
Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Caroline Dancyger, Philippa Renouf, William Ricketts, Adam Januszewski, Mersaydiz Hudson, Abbie Unwin Tags: Nursing and Allied Health Professionals Source Type: research
111 Patient, professional and carer experiences of communicating a lung cancer diagnosis: A systematic review of qualitative evidence
People with lung cancer, and those who support them, require clear and consistent communication from their healthcare providers to support their engagement in diagnostic and treatment pathways. No systematic review exists that reports on people's qualitative experiences surrounding the communication of a lung cancer diagnosis and subsequent treatment options. This review aimed to identify and synthesise qualitative evidence surrounding patients ’, carers’, and healthcare professionals’ experiences of communicating a lung cancer diagnosis and treatment. (Source: Lung Cancer)
Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Samuel Cooke, Yordanos Gebre, Jessica Clark, Aslihan Arslan Argin, Ros Kane, Samantha L Quaife, Daisy McInnerney, Lucy Mitchinson, Zara Pogson, Dawn Skinner, Sarah Civello, Ava Harding-Bell, Lynn Calman, Peter Selby, Brian Knowles, Michael D Peake, David Tags: Nursing and Allied Health Professionals Source Type: research
112 A novel tool development, identifying the unmet rehabilitation needs of lung cancer patients at diagnosisa pilot study
Patients diagnosed with lung cancer often present with advanced disease (26,100 cases (65.6%) per year) and multiple comorbidities [1, 2]. The coexistence of advanced lung cancer and comorbidities leads to significant symptom burden, necessitating prompt assessment and intervention to optimise function, independence and quality of life. In August 2023, we conducted a preliminary study that involved redesigning a local allied health professional (AHP) rehabilitation screening tool for identifying and stratifying the rehabilitation intervention needs of lung cancer patients at the time of diagnosis. (Source: Lung Cancer)
Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Emma Palmer, Ryan Lian, Nicola Peat Tags: Nursing and Allied Health Professionals Source Type: research
113 Optimising physical performance and improving treatment tolerance in a lung cancer patient with comorbidities: a case study of allied health intervention across the phases of rehabilitation
Lung cancer patients have a high symptom burden compared to other tumour groups. Combined with a growing multimorbid population, specialised management is imperative to optimise physical performance and treatment tolerance throughout all phases of the Dietz Rehabilitation Model. At Guy's Cancer Centre, an allied health team consisting of Physiotherapy, Occupational Therapy, Dietetics and Speech and Language Therapy (SLT) work alongside the Oncologist-led clinic to support this patient group. (Source: Lung Cancer)
Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Emma Palmer, Ashton Brower, Megan Geytenbeek, Elizabeth Quirke Tags: Nursing and Allied Health Professionals Source Type: research
114 The role of the Patient Cancer Care Coordinator in the Lung Cancer Pathway – reducing health inequalities and optimising patient access
Lung Cancer is known to be a complex and evolving tumour site across the cancer arena – necessitating an ever increasingly personalised response to care management and planning. In recognising this, the non-clinical Patient Cancer Care Coordinator (PCCC) role was established as one year pilot to support coordination of complex pathways and provide focused support for ‘hard to rea ch’ patients to reduce health inequalities. (Source: Lung Cancer)
Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Richard Sterry, Andrea Worsdale, Leah Taylor, Mark Weatherhead Tags: Nursing and Allied Health Professionals Source Type: research
115 Early identification of functional problems and self-management support for people with thoracic cancers using an Allied Health Professional Screening Tool - An audit report
Those diagnosed with thoracic malignancies experience complex symptoms and functional impairments. Patient experience research has highlighted that tailored rehabilitation around the time of diagnosis, supports people to self-manage symptoms and, remain more independent when treated for cancer1. However, best practice to identify problems early remains to be determined. We introduced a new patient information pack, sent with the first appointment to the Cancer Centre by administrative staff including: (Source: Lung Cancer)
Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Catherine Sandsund, Sarah Sarker, Karen Bottomley-Wise, Siobhan Cowan-Dickie Tags: Nursing and Allied Health Professionals Source Type: research
116 Health and Wellbeing days for Lung Cancer patients
Within the Great Western Hospital, a Macmillan Personalised care team was formed in 2021, as a team they introduced site specific health and wellbeing days, along with several other services. These days are designed for individuals with a diagnosis of Lung cancer, to provide site specific advice and support around various topics. These topics are chosen specifically to suit patient's needs, following information taken from holistic needs assessment data. (Source: Lung Cancer)
Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Sarah Tasker, Carlene Rutherford, Rachel Smith Tags: Nursing and Allied Health Professionals Source Type: research
117 Prognostic factors for 90-day acute care outcomes in lung cancer patients 70 and over
Lung cancer treatment guidelines are based on studies with relatively fit (PS 0-1) and young patients ( ≤70). However, the average UK lung cancer patient is 74 and often has significant comorbidity and frailty, which impacts on outcome. Our aim was to determine the impact of frailty on 90-day acute care outcomes in lung cancer patients at a single tertiary centre. (Source: Lung Cancer)
Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: David Cobben, Bridget Taylor, Helen Wong, Carles Escriu Tags: Other Source Type: research
118 Occupational causes of respiratory cancers: Current and emerging trends and promoting prevention
Every year around 6,300 incidents of lung cancers (13% of the UK's total lung cancer cases) result from occupational exposures in the workplace. Workplace respiratory cancer therefore presents a significant burden to medical professions. By understanding current and emerging trends in occupational causes of lung cancer and the risks associated with exposures to certain substances, early identification of potential cases can be considered by assessment of the patient's working history. (Source: Lung Cancer)
Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Tina Conroy, Rosie MacKay Tags: Other Source Type: research
119 Estimating the health benefits of introducing ctDNA next generation sequencing to the diagnostic pathway for advanced lung cancer: A modelling study
Increasing availability of first-line targeted treatments has made next generation sequencing (NGS) essential for optimal treatment decisions in advanced non-small cell lung cancer (aNSCLC). Factors including biopsy feasibility, sample quality, failure rates and report turn-around times are significant barriers to timely and complete profiling with standard-of-care (SoC) tissue-based genotyping. Blood-based ctDNA NGS technologies may overcome these barriers. NHS England drug commissioning criteria allow treatment based on radiological findings and an informative Tier 1 ctDNA NGS result. (Source: Lung Cancer)
Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Neal Navani, Alexander van Doornewaard, Verena Schneider, Phoebe Marson Smith, Riyaz Shah, Alastair Greystoke, Matthew Krebs, Sophie Scott, Iris Faull, Elisabeth Adams, Sanjay Popat Tags: Other Source Type: research
